List of Tables
Table 1. Global Plasma-derived Medicinal Products Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Plasma-derived Medicinal Products Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Plasma-derived Medicinal Products Market Competitive Situation by Manufacturers in 2023
Table 4. Global Plasma-derived Medicinal Products Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Plasma-derived Medicinal Products Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Plasma-derived Medicinal Products Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Plasma-derived Medicinal Products Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Plasma-derived Medicinal Products Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Plasma-derived Medicinal Products, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Plasma-derived Medicinal Products, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Plasma-derived Medicinal Products, Product Type & Application
Table 12. Global Key Manufacturers of Plasma-derived Medicinal Products, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Plasma-derived Medicinal Products by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma-derived Medicinal Products as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Plasma-derived Medicinal Products Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Plasma-derived Medicinal Products Sales by Region (2019-2024) & (K Units)
Table 18. Global Plasma-derived Medicinal Products Sales Market Share by Region (2019-2024)
Table 19. Global Plasma-derived Medicinal Products Sales by Region (2025-2030) & (K Units)
Table 20. Global Plasma-derived Medicinal Products Sales Market Share by Region (2025-2030)
Table 21. Global Plasma-derived Medicinal Products Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Plasma-derived Medicinal Products Revenue Market Share by Region (2019-2024)
Table 23. Global Plasma-derived Medicinal Products Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Plasma-derived Medicinal Products Revenue Market Share by Region (2025-2030)
Table 25. North America Plasma-derived Medicinal Products Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Plasma-derived Medicinal Products Sales by Country (2019-2024) & (K Units)
Table 27. North America Plasma-derived Medicinal Products Sales by Country (2025-2030) & (K Units)
Table 28. North America Plasma-derived Medicinal Products Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Plasma-derived Medicinal Products Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Plasma-derived Medicinal Products Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Plasma-derived Medicinal Products Sales by Country (2019-2024) & (K Units)
Table 32. Europe Plasma-derived Medicinal Products Sales by Country (2025-2030) & (K Units)
Table 33. Europe Plasma-derived Medicinal Products Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Plasma-derived Medicinal Products Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Plasma-derived Medicinal Products Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Plasma-derived Medicinal Products Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Plasma-derived Medicinal Products Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Plasma-derived Medicinal Products Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Plasma-derived Medicinal Products Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Plasma-derived Medicinal Products Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Plasma-derived Medicinal Products Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Plasma-derived Medicinal Products Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Plasma-derived Medicinal Products Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Plasma-derived Medicinal Products Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Plasma-derived Medicinal Products Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Plasma-derived Medicinal Products Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Plasma-derived Medicinal Products Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Plasma-derived Medicinal Products Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Plasma-derived Medicinal Products Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Plasma-derived Medicinal Products Sales (K Units) by Type (2019-2024)
Table 51. Global Plasma-derived Medicinal Products Sales (K Units) by Type (2025-2030)
Table 52. Global Plasma-derived Medicinal Products Sales Market Share by Type (2019-2024)
Table 53. Global Plasma-derived Medicinal Products Sales Market Share by Type (2025-2030)
Table 54. Global Plasma-derived Medicinal Products Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Plasma-derived Medicinal Products Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Plasma-derived Medicinal Products Revenue Market Share by Type (2019-2024)
Table 57. Global Plasma-derived Medicinal Products Revenue Market Share by Type (2025-2030)
Table 58. Global Plasma-derived Medicinal Products Price (US$/Unit) by Type (2019-2024)
Table 59. Global Plasma-derived Medicinal Products Price (US$/Unit) by Type (2025-2030)
Table 60. Global Plasma-derived Medicinal Products Sales (K Units) by Application (2019-2024)
Table 61. Global Plasma-derived Medicinal Products Sales (K Units) by Application (2025-2030)
Table 62. Global Plasma-derived Medicinal Products Sales Market Share by Application (2019-2024)
Table 63. Global Plasma-derived Medicinal Products Sales Market Share by Application (2025-2030)
Table 64. Global Plasma-derived Medicinal Products Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Plasma-derived Medicinal Products Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Plasma-derived Medicinal Products Revenue Market Share by Application (2019-2024)
Table 67. Global Plasma-derived Medicinal Products Revenue Market Share by Application (2025-2030)
Table 68. Global Plasma-derived Medicinal Products Price (US$/Unit) by Application (2019-2024)
Table 69. Global Plasma-derived Medicinal Products Price (US$/Unit) by Application (2025-2030)
Table 70. Takeda Corporation Information
Table 71. Takeda Description and Business Overview
Table 72. Takeda Plasma-derived Medicinal Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Takeda Plasma-derived Medicinal Products Product
Table 74. Takeda Recent Developments/Updates
Table 75. CSL Corporation Information
Table 76. CSL Description and Business Overview
Table 77. CSL Plasma-derived Medicinal Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. CSL Plasma-derived Medicinal Products Product
Table 79. CSL Recent Developments/Updates
Table 80. Grifols Corporation Information
Table 81. Grifols Description and Business Overview
Table 82. Grifols Plasma-derived Medicinal Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Grifols Plasma-derived Medicinal Products Product
Table 84. Grifols Recent Developments/Updates
Table 85. Octapharma Corporation Information
Table 86. Octapharma Description and Business Overview
Table 87. Octapharma Plasma-derived Medicinal Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Octapharma Plasma-derived Medicinal Products Product
Table 89. Octapharma Recent Developments/Updates
Table 90. Kedrion Corporation Information
Table 91. Kedrion Description and Business Overview
Table 92. Kedrion Plasma-derived Medicinal Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Kedrion Plasma-derived Medicinal Products Product
Table 94. Kedrion Recent Developments/Updates
Table 95. LFB Group Corporation Information
Table 96. LFB Group Description and Business Overview
Table 97. LFB Group Plasma-derived Medicinal Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. LFB Group Plasma-derived Medicinal Products Product
Table 99. LFB Group Recent Developments/Updates
Table 100. Biotest Corporation Information
Table 101. Biotest Description and Business Overview
Table 102. Biotest Plasma-derived Medicinal Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Biotest Plasma-derived Medicinal Products Product
Table 104. Biotest Recent Developments/Updates
Table 105. BPL Corporation Information
Table 106. BPL Description and Business Overview
Table 107. BPL Plasma-derived Medicinal Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. BPL Plasma-derived Medicinal Products Product
Table 109. BPL Recent Developments/Updates
Table 110. Shanghai RAAS Corporation Information
Table 111. Shanghai RAAS Description and Business Overview
Table 112. Shanghai RAAS Plasma-derived Medicinal Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Shanghai RAAS Plasma-derived Medicinal Products Product
Table 114. Shanghai RAAS Recent Developments/Updates
Table 115. China Biologic Products Corporation Information
Table 116. China Biologic Products Description and Business Overview
Table 117. China Biologic Products Plasma-derived Medicinal Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. China Biologic Products Plasma-derived Medicinal Products Product
Table 119. China Biologic Products Recent Developments/Updates
Table 120. Hualan Biological Engineering Inc. Corporation Information
Table 121. Hualan Biological Engineering Inc. Description and Business Overview
Table 122. Hualan Biological Engineering Inc. Plasma-derived Medicinal Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Hualan Biological Engineering Inc. Plasma-derived Medicinal Products Product
Table 124. Hualan Biological Engineering Inc. Recent Developments/Updates
Table 125. Beijing Tiantan Biological Products Corp Corporation Information
Table 126. Beijing Tiantan Biological Products Corp Description and Business Overview
Table 127. Beijing Tiantan Biological Products Corp Plasma-derived Medicinal Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Beijing Tiantan Biological Products Corp Plasma-derived Medicinal Products Product
Table 129. Beijing Tiantan Biological Products Corp Recent Developments/Updates
Table 130. Pacific Shuanglin Corporation Information
Table 131. Pacific Shuanglin Description and Business Overview
Table 132. Pacific Shuanglin Plasma-derived Medicinal Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Pacific Shuanglin Plasma-derived Medicinal Products Product
Table 134. Pacific Shuanglin Recent Developments/Updates
Table 135. Boya Bio-Pharmaceutical Corporation Information
Table 136. Boya Bio-Pharmaceutical Description and Business Overview
Table 137. Boya Bio-Pharmaceutical Plasma-derived Medicinal Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Boya Bio-Pharmaceutical Plasma-derived Medicinal Products Product
Table 139. Boya Bio-Pharmaceutical Recent Developments/Updates
Table 140. Paisi Feike Biology Pharmacy Co., Ltd. Corporation Information
Table 141. Paisi Feike Biology Pharmacy Co., Ltd. Description and Business Overview
Table 142. Paisi Feike Biology Pharmacy Co., Ltd. Plasma-derived Medicinal Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Paisi Feike Biology Pharmacy Co., Ltd. Plasma-derived Medicinal Products Product
Table 144. Paisi Feike Biology Pharmacy Co., Ltd. Recent Developments/Updates
Table 145. Xinjiang Deyuan Bioengineering Corporation Information
Table 146. Xinjiang Deyuan Bioengineering Description and Business Overview
Table 147. Xinjiang Deyuan Bioengineering Plasma-derived Medicinal Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. Xinjiang Deyuan Bioengineering Plasma-derived Medicinal Products Product
Table 149. Xinjiang Deyuan Bioengineering Recent Developments/Updates
Table 150. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Corporation Information
Table 151. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Description and Business Overview
Table 152. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma-derived Medicinal Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 153. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma-derived Medicinal Products Product
Table 154. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 155. Shenzhen Weiguang Corporation Information
Table 156. Shenzhen Weiguang Description and Business Overview
Table 157. Shenzhen Weiguang Plasma-derived Medicinal Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 158. Shenzhen Weiguang Plasma-derived Medicinal Products Product
Table 159. Shenzhen Weiguang Recent Developments/Updates
Table 160. Shanxi Kangbao Corporation Information
Table 161. Shanxi Kangbao Description and Business Overview
Table 162. Shanxi Kangbao Plasma-derived Medicinal Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 163. Shanxi Kangbao Plasma-derived Medicinal Products Product
Table 164. Shanxi Kangbao Recent Developments/Updates
Table 165. Nanyue Biopharming Corporation Ltd Corporation Information
Table 166. Nanyue Biopharming Corporation Ltd Description and Business Overview
Table 167. Nanyue Biopharming Corporation Ltd Plasma-derived Medicinal Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 168. Nanyue Biopharming Corporation Ltd Plasma-derived Medicinal Products Product
Table 169. Nanyue Biopharming Corporation Ltd Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Plasma-derived Medicinal Products Distributors List
Table 173. Plasma-derived Medicinal Products Customers List
Table 174. Plasma-derived Medicinal Products Market Trends
Table 175. Plasma-derived Medicinal Products Market Drivers
Table 176. Plasma-derived Medicinal Products Market Challenges
Table 177. Plasma-derived Medicinal Products Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Plasma-derived Medicinal Products
Figure 2. Global Plasma-derived Medicinal Products Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Plasma-derived Medicinal Products Market Share by Type in 2023 & 2030
Figure 4. Immunoglobulins Product Picture
Figure 5. Coagulation Factor Concentrates Product Picture
Figure 6. Other Product Picture
Figure 7. Global Plasma-derived Medicinal Products Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Plasma-derived Medicinal Products Market Share by Application in 2023 & 2030
Figure 9. Emergency Care
Figure 10. Epidemic Diseasae
Figure 11. Immune System Disorder
Figure 12. Antibody Deficiency
Figure 13. Coagulation Disorder
Figure 14. Others
Figure 15. Global Plasma-derived Medicinal Products Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Plasma-derived Medicinal Products Market Size (2019-2030) & (US$ Million)
Figure 17. Global Plasma-derived Medicinal Products Sales (2019-2030) & (K Units)
Figure 18. Global Plasma-derived Medicinal Products Average Price (US$/Unit) & (2019-2030)
Figure 19. Plasma-derived Medicinal Products Report Years Considered
Figure 20. Plasma-derived Medicinal Products Sales Share by Manufacturers in 2023
Figure 21. Global Plasma-derived Medicinal Products Revenue Share by Manufacturers in 2023
Figure 22. The Global 5 and 10 Largest Plasma-derived Medicinal Products Players: Market Share by Revenue in 2023
Figure 23. Plasma-derived Medicinal Products Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 24. Global Plasma-derived Medicinal Products Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 25. North America Plasma-derived Medicinal Products Sales Market Share by Country (2019-2030)
Figure 26. North America Plasma-derived Medicinal Products Revenue Market Share by Country (2019-2030)
Figure 27. United States Plasma-derived Medicinal Products Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Canada Plasma-derived Medicinal Products Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Europe Plasma-derived Medicinal Products Sales Market Share by Country (2019-2030)
Figure 30. Europe Plasma-derived Medicinal Products Revenue Market Share by Country (2019-2030)
Figure 31. Germany Plasma-derived Medicinal Products Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. France Plasma-derived Medicinal Products Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. U.K. Plasma-derived Medicinal Products Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Italy Plasma-derived Medicinal Products Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Russia Plasma-derived Medicinal Products Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Asia Pacific Plasma-derived Medicinal Products Sales Market Share by Region (2019-2030)
Figure 37. Asia Pacific Plasma-derived Medicinal Products Revenue Market Share by Region (2019-2030)
Figure 38. China Plasma-derived Medicinal Products Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Japan Plasma-derived Medicinal Products Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. South Korea Plasma-derived Medicinal Products Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. India Plasma-derived Medicinal Products Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Australia Plasma-derived Medicinal Products Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. China Taiwan Plasma-derived Medicinal Products Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Indonesia Plasma-derived Medicinal Products Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Thailand Plasma-derived Medicinal Products Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Malaysia Plasma-derived Medicinal Products Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Latin America Plasma-derived Medicinal Products Sales Market Share by Country (2019-2030)
Figure 48. Latin America Plasma-derived Medicinal Products Revenue Market Share by Country (2019-2030)
Figure 49. Mexico Plasma-derived Medicinal Products Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Brazil Plasma-derived Medicinal Products Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Argentina Plasma-derived Medicinal Products Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Middle East & Africa Plasma-derived Medicinal Products Sales Market Share by Country (2019-2030)
Figure 53. Middle East & Africa Plasma-derived Medicinal Products Revenue Market Share by Country (2019-2030)
Figure 54. Turkey Plasma-derived Medicinal Products Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Saudi Arabia Plasma-derived Medicinal Products Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. UAE Plasma-derived Medicinal Products Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 57. Global Sales Market Share of Plasma-derived Medicinal Products by Type (2019-2030)
Figure 58. Global Revenue Market Share of Plasma-derived Medicinal Products by Type (2019-2030)
Figure 59. Global Plasma-derived Medicinal Products Price (US$/Unit) by Type (2019-2030)
Figure 60. Global Sales Market Share of Plasma-derived Medicinal Products by Application (2019-2030)
Figure 61. Global Revenue Market Share of Plasma-derived Medicinal Products by Application (2019-2030)
Figure 62. Global Plasma-derived Medicinal Products Price (US$/Unit) by Application (2019-2030)
Figure 63. Plasma-derived Medicinal Products Value Chain
Figure 64. Plasma-derived Medicinal Products Production Process
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Distributors Profiles
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
